Personal tools

Coexpression cluster:C198: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 3: Line 3:
|gostat_on_coexpression_clusters=GO:0006817!phosphate transport!0.000475071195691557!1292;1291$GO:0015698!inorganic anion transport!0.000787730087606359!1292;1291$GO:0006820!anion transport!0.000794760467509113!1292;1291$GO:0005589!collagen type VI!0.000794760467509113!1291$GO:0005578!proteinaceous extracellular matrix!0.000827362245860152!1292;1291$GO:0030934!anchoring collagen!0.00238403574865387!1291$GO:0044421!extracellular region part!0.00239321462513256!1292;1291$GO:0022610!biological adhesion!0.00239321462513256!1292;1291$GO:0007155!cell adhesion!0.00239321462513256!1292;1291$GO:0006811!ion transport!0.00434955216285057!1292;1291$GO:0030198!extracellular matrix organization and biogenesis!0.00664278275475231!1292$GO:0005581!collagen!0.0071473696355446!1291$GO:0043062!extracellular structure organization and biogenesis!0.0102583545846563!1292$GO:0030674!protein binding, bridging!0.0103183517189704!1292$GO:0005201!extracellular matrix structural constituent!0.012989492507796!1292$GO:0044420!extracellular matrix part!0.012989492507796!1291$GO:0006810!transport!0.0222181450900092!1292;1291$GO:0051234!establishment of localization!0.0222181450900092!1292;1291$GO:0051179!localization!0.0247191580527521!1292;1291$GO:0016337!cell-cell adhesion!0.0274381479679809!1292
|gostat_on_coexpression_clusters=GO:0006817!phosphate transport!0.000475071195691557!1292;1291$GO:0015698!inorganic anion transport!0.000787730087606359!1292;1291$GO:0006820!anion transport!0.000794760467509113!1292;1291$GO:0005589!collagen type VI!0.000794760467509113!1291$GO:0005578!proteinaceous extracellular matrix!0.000827362245860152!1292;1291$GO:0030934!anchoring collagen!0.00238403574865387!1291$GO:0044421!extracellular region part!0.00239321462513256!1292;1291$GO:0022610!biological adhesion!0.00239321462513256!1292;1291$GO:0007155!cell adhesion!0.00239321462513256!1292;1291$GO:0006811!ion transport!0.00434955216285057!1292;1291$GO:0030198!extracellular matrix organization and biogenesis!0.00664278275475231!1292$GO:0005581!collagen!0.0071473696355446!1291$GO:0043062!extracellular structure organization and biogenesis!0.0102583545846563!1292$GO:0030674!protein binding, bridging!0.0103183517189704!1292$GO:0005201!extracellular matrix structural constituent!0.012989492507796!1292$GO:0044420!extracellular matrix part!0.012989492507796!1291$GO:0006810!transport!0.0222181450900092!1292;1291$GO:0051234!establishment of localization!0.0222181450900092!1292;1291$GO:0051179!localization!0.0247191580527521!1292;1291$GO:0016337!cell-cell adhesion!0.0274381479679809!1292
|id=C198
|id=C198
|ontology_enrichment_celltype=CL:0000055!1.08e-47!180;CL:0000057!8.20e-25!75;CL:0000680!8.14e-19!57;CL:0000056!8.14e-19!57;CL:0000355!8.14e-19!57;CL:0000183!1.67e-18!59;CL:0000187!3.92e-18!54;CL:0000393!7.73e-18!60;CL:0000211!7.73e-18!60;CL:0000192!6.20e-14!42;CL:0000514!6.20e-14!42;CL:0000359!1.26e-10!32;CL:0002620!8.42e-10!23;CL:0000222!9.57e-10!119;CL:0000499!9.07e-08!27
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0000914!6.46e-25!83;UBERON:0002329!6.46e-25!83;UBERON:0003077!6.46e-25!83;UBERON:0003059!6.46e-25!83;UBERON:0007282!6.46e-25!83;UBERON:0009618!6.46e-25!83;UBERON:0007285!6.46e-25!83;UBERON:0004290!3.00e-23!70;UBERON:0005256!9.28e-22!143;UBERON:0000486!8.67e-20!82;UBERON:0002385!1.84e-19!63;UBERON:0001015!1.84e-19!63;UBERON:0000383!1.84e-19!63;UBERON:0001134!3.11e-19!61;UBERON:0002036!3.11e-19!61;UBERON:0003082!3.11e-19!61;UBERON:0000475!7.68e-19!365;UBERON:0000481!4.66e-15!347;UBERON:0002100!6.48e-15!216;UBERON:0003102!3.73e-12!95;UBERON:0003104!1.25e-11!238;UBERON:0009142!1.25e-11!238;UBERON:0000468!2.61e-11!659;UBERON:0002199!4.10e-10!45;UBERON:0002416!4.10e-10!45;UBERON:0000119!1.06e-08!312;UBERON:0001013!1.29e-08!14;UBERON:0004872!1.31e-08!84;UBERON:0000483!2.40e-08!309;UBERON:0000490!4.64e-08!138;UBERON:0002097!9.46e-08!40;UBERON:0000467!2.73e-07!625;UBERON:0000480!2.98e-07!626;UBERON:0003914!3.09e-07!118;UBERON:0004573!3.41e-07!33;UBERON:0004571!3.41e-07!33;UBERON:0001637!4.27e-07!42;UBERON:0003509!4.27e-07!42;UBERON:0004572!4.27e-07!42
}}
}}

Revision as of 14:18, 21 May 2012


Full id: C198_Mesenchymal_Hair_Hepatic_Fibroblast_Smooth_tenocyte_Pericytes



Phase1 CAGE Peaks

Hg19::chr15:74468156..74468168,+p@chr15:74468156..74468168
+
Hg19::chr21:47401650..47401692,+p1@COL6A1
Hg19::chr21:47402595..47402613,+p@chr21:47402595..47402613
+
Hg19::chr21:47404171..47404205,+p@chr21:47404171..47404205
+
Hg19::chr21:47404201..47404227,-p@chr21:47404201..47404227
-
Hg19::chr21:47404207..47404295,+p@chr21:47404207..47404295
+
Hg19::chr21:47404302..47404340,+p@chr21:47404302..47404340
+
Hg19::chr21:47404327..47404375,-p@chr21:47404327..47404375
-
Hg19::chr21:47406434..47406447,+p@chr21:47406434..47406447
+
Hg19::chr21:47406480..47406493,-p@chr21:47406480..47406493
-
Hg19::chr21:47406517..47406541,+p6@COL6A1
Hg19::chr21:47406543..47406568,+p5@COL6A1
Hg19::chr21:47406856..47406869,+p15@COL6A1
Hg19::chr21:47406885..47406955,+p2@COL6A1
Hg19::chr21:47406935..47406993,-p@chr21:47406935..47406993
-
Hg19::chr21:47407540..47407554,-p@chr21:47407540..47407554
-
Hg19::chr21:47408990..47409018,+p@chr21:47408990..47409018
+
Hg19::chr21:47409532..47409537,+p@chr21:47409532..47409537
+
Hg19::chr21:47409561..47409573,-p@chr21:47409561..47409573
-
Hg19::chr21:47409685..47409693,-p@chr21:47409685..47409693
-
Hg19::chr21:47410165..47410170,+p@chr21:47410165..47410170
+
Hg19::chr21:47410279..47410304,+p@chr21:47410279..47410304
+
Hg19::chr21:47410688..47410701,+p@chr21:47410688..47410701
+
Hg19::chr21:47410932..47410962,-p@chr21:47410932..47410962
-
Hg19::chr21:47412107..47412140,-p@chr21:47412107..47412140
-
Hg19::chr21:47418034..47418040,+p@chr21:47418034..47418040
+
Hg19::chr21:47418307..47418324,+p@chr21:47418307..47418324
+
Hg19::chr21:47418813..47418822,+p3@COL6A1
Hg19::chr21:47421885..47421916,+p9@COL6A1
Hg19::chr21:47421929..47421942,+p19@COL6A1
Hg19::chr21:47422170..47422205,+p4@COL6A1
Hg19::chr21:47422241..47422263,+p7@COL6A1
Hg19::chr21:47422530..47422542,+p13@COL6A1
Hg19::chr21:47423457..47423466,+p@chr21:47423457..47423466
+
Hg19::chr21:47423500..47423511,+p@chr21:47423500..47423511
+
Hg19::chr21:47423769..47423786,+p@chr21:47423769..47423786
+
Hg19::chr21:47423911..47423979,+p@chr21:47423911..47423979
+
Hg19::chr21:47423986..47424046,-p@chr21:47423986..47424046
-
Hg19::chr21:47424225..47424238,+p@chr21:47424225..47424238
+
Hg19::chr21:47424253..47424260,+p@chr21:47424253..47424260
+
Hg19::chr21:47424266..47424304,+p@chr21:47424266..47424304
+
Hg19::chr21:47424373..47424395,+p@chr21:47424373..47424395
+
Hg19::chr21:47424418..47424444,+p@chr21:47424418..47424444
+
Hg19::chr21:47424561..47424570,+p@chr21:47424561..47424570
+
Hg19::chr21:47424604..47424616,+p@chr21:47424604..47424616
+
Hg19::chr21:47424675..47424687,+p@chr21:47424675..47424687
+
Hg19::chr21:47518016..47518071,+p1@COL6A2
Hg19::chr21:47518637..47518688,+p2@COL6A2
Hg19::chr21:47518695..47518709,+p6@COL6A2
Hg19::chr21:47531348..47531389,+p10@COL6A2
Hg19::chr21:47531422..47531446,+p14@COL6A2
Hg19::chr21:47531453..47531471,+p13@COL6A2
Hg19::chr21:47531482..47531512,-p@chr21:47531482..47531512
-
Hg19::chr21:47531911..47531959,-p@chr21:47531911..47531959
-
Hg19::chr21:47531929..47531974,+p12@COL6A2
Hg19::chr21:47532028..47532078,+p4@COL6A2
Hg19::chr21:47532083..47532106,+p11@COL6A2
Hg19::chr21:47532107..47532192,+p5@COL6A2
Hg19::chr21:47532226..47532238,+p28@COL6A2
Hg19::chr21:47532285..47532298,+p18@COL6A2
Hg19::chr21:47532318..47532355,+p8@COL6A2
Hg19::chr21:47532365..47532492,-p@chr21:47532365..47532492
-
Hg19::chr21:47532366..47532425,+p3@COL6A2
Hg19::chr21:47535780..47535815,+p17@COL6A2
Hg19::chr21:47535916..47535938,+p21@COL6A2
Hg19::chr21:47536285..47536294,+p@chr21:47536285..47536294
+
Hg19::chr21:47539710..47539714,+p@chr21:47539710..47539714
+
Hg19::chr21:47540424..47540442,+p27@COL6A2
Hg19::chr21:47542827..47542859,-p@chr21:47542827..47542859
-
Hg19::chr21:47545494..47545526,-p@chr21:47545494..47545526
-
Hg19::chr21:47545703..47545747,+p15@COL6A2
Hg19::chr21:47545788..47545804,+p42@COL6A2
Hg19::chr21:47545812..47545838,+p22@COL6A2
Hg19::chr21:47545905..47545936,+p23@COL6A2
Hg19::chr21:47545938..47545951,+p19@COL6A2
Hg19::chr21:47545961..47545972,+p37@COL6A2
Hg19::chr21:47546004..47546019,+p26@COL6A2
Hg19::chr21:47546031..47546052,+p29@COL6A2
Hg19::chr21:47546401..47546428,+p40@COL6A2
Hg19::chr21:47549257..47549279,+p44@COL6A2
Hg19::chr21:47551929..47551951,+p24@COL6A2
Hg19::chr21:47551979..47551997,+p20@COL6A2
Hg19::chr21:47552005..47552020,+p7@COL6A2
Hg19::chr21:47552113..47552127,+p36@COL6A2


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data

GO IDGO nameFDR corrected p-value
GO:0006817phosphate transport0.000475071195691557
GO:0015698inorganic anion transport0.000787730087606359
GO:0006820anion transport0.000794760467509113
GO:0005589collagen type VI0.000794760467509113
GO:0005578proteinaceous extracellular matrix0.000827362245860152
GO:0030934anchoring collagen0.00238403574865387
GO:0044421extracellular region part0.00239321462513256
GO:0022610biological adhesion0.00239321462513256
GO:0007155cell adhesion0.00239321462513256
GO:0006811ion transport0.00434955216285057
GO:0030198extracellular matrix organization and biogenesis0.00664278275475231
GO:0005581collagen0.0071473696355446
GO:0043062extracellular structure organization and biogenesis0.0102583545846563
GO:0030674protein binding, bridging0.0103183517189704
GO:0005201extracellular matrix structural constituent0.012989492507796
GO:0044420extracellular matrix part0.012989492507796
GO:0006810transport0.0222181450900092
GO:0051234establishment of localization0.0222181450900092
GO:0051179localization0.0247191580527521
GO:0016337cell-cell adhesion0.0274381479679809



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>

Uber Anatomy
Ontology termp-valuen
somite6.46e-2583
paraxial mesoderm6.46e-2583
presomitic mesoderm6.46e-2583
presumptive segmental plate6.46e-2583
trunk paraxial mesoderm6.46e-2583
presumptive paraxial mesoderm6.46e-2583
dermomyotome3.00e-2370
trunk mesenchyme9.28e-22143
multilaminar epithelium8.67e-2082
muscle tissue1.84e-1963
musculature1.84e-1963
musculature of body1.84e-1963
skeletal muscle tissue3.11e-1961
striated muscle tissue3.11e-1961
myotome3.11e-1961
organism subdivision7.68e-19365
multi-tissue structure4.66e-15347
trunk6.48e-15216
surface structure3.73e-1295
mesenchyme1.25e-11238
entire embryonic mesenchyme1.25e-11238
multi-cellular organism2.61e-11659
integument4.10e-1045
integumental system4.10e-1045
cell layer1.06e-08312
adipose tissue1.29e-0814
splanchnic layer of lateral plate mesoderm1.31e-0884
epithelium2.40e-08309
unilaminar epithelium4.64e-08138
skin of body9.46e-0840
anatomical system2.73e-07625
anatomical group2.98e-07626
epithelial tube3.09e-07118
systemic artery3.41e-0733
systemic arterial system3.41e-0733
artery4.27e-0742
arterial blood vessel4.27e-0742
arterial system4.27e-0742


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data

No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data

"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=Coexpression_cluster:C198&oldid=1704682"